Niagen Bioscience, Inc.
NAGE
$4.78
-$0.04-0.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.13M | 4.58M | 3.61M | 5.06M | 7.18M |
| Total Depreciation and Amortization | 199.00K | 195.00K | 196.00K | 195.00K | 189.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.00K | 1.92M | 1.75M | -56.00K | -3.90M |
| Change in Net Operating Assets | -3.67M | -3.00M | -4.30M | 2.68M | 5.11M |
| Cash from Operations | 679.00K | 3.69M | 1.25M | 7.88M | 8.58M |
| Capital Expenditure | -101.00K | -24.00K | -135.00K | -32.00K | -69.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -101.00K | -24.00K | -135.00K | -32.00K | -69.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.00K | -4.00K | -3.00K | -3.00K | -2.00K |
| Issuance of Common Stock | 228.00K | 152.00K | 3.75M | 3.11M | 3.79M |
| Repurchase of Common Stock | -251.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -55.00K | 0.00 | -6.00K | -6.00K | -41.00K |
| Cash from Financing | -80.00K | 148.00K | 3.74M | 3.11M | 3.75M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 498.00K | 3.82M | 4.86M | 10.96M | 12.26M |